Cargando…

Treatment of corneal neovascularization in ocular chemical injury with an off-label use of subconjunctival bevacizumab: a case report

INTRODUCTION: In this report, we describe the case of a patient with ocular chemical injury, symblepharon, and corneal neovascularization in whom subconjunctival injection of bevacizumab caused regression of corneal opacification and neovascularization, which led to visual improvement. CASE PRESENTA...

Descripción completa

Detalles Bibliográficos
Autores principales:	Iannetti, Ludovico, Abbouda, Alessandro, Fabiani, Claudia, Zito, Roberta, Campanella, Michelangelo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3750591/ https://www.ncbi.nlm.nih.gov/pubmed/23889894 http://dx.doi.org/10.1186/1752-1947-7-199

Ejemplares similares

Resolution of Refractory Corneal Neovascularization with Subconjunctival Bevacizumab
por: Britton, Anna Krystyna, et al.
Publicado: (2020)

Successful regression of newly formed corneal neovascularization by subconjunctival injection of bevacizumab in patients with chemical burns
por: Peng, Wen-yan, et al.
Publicado: (2023)

The effect of subconjunctival bevacizumab on corneal neovascularization, inflammation and re-epithelization in a rabbit model
por: Mello, Glauco Reggiani, et al.
Publicado: (2011)

Comparison of different doses of subconjunctival sunitinib with bevacizumab in the treatment of corneal neovascularization in experimental rats
por: Hashemian, Mohammad Nasser, et al.
Publicado: (2017)

Regression of Iris Neovascularization after Subconjunctival Injection of Bevacizumab
por: Ryoo, Na Kyung, et al.
Publicado: (2013)

Inhibition of Corneal Neovascularization by Topical and Subconjunctival Tigecycline
por: Goktas, Sertan, et al.
Publicado: (2014)

Short-term regression of corneal neovascularization with combination therapy of argon green laser photocoagulation and subconjunctival bevacizumab
por: Anand, Nandita, et al.
Publicado: (2019)

Topical versus subconjunctival anti-vascular endothelial growth factor therapy (Bevacizumab, Ranibizumab and Aflibercept) for treatment of corneal neovascularization
por: Al-Debasi, Tariq, et al.
Publicado: (2017)

The Effect of Bevacizumab on Corneal Neovascularization in Rabbits
por: Kim, Wung-Jae, et al.
Publicado: (2010)

Subconjunctival bevacizumab and argon laser photocoagulation for preexisting neovascularization following deep lamellar anterior keratoplasty
por: Lakshmipathy, Meena, et al.
Publicado: (2019)

Inhibition of Corneal Neovascularization by Subconjunctival Injection of Fc-Endostatin, a Novel Inhibitor of Angiogenesis
por: Yoshida, Junko, et al.
Publicado: (2015)

Subconjunctival injection of antagomir-21 alleviates corneal neovascularization in a mouse model of alkali-burned cornea
por: Zhang, Yun, et al.
Publicado: (2016)

Ranibizumab Injection for Corneal Neovascularization Refractory to Bevacizumab Treatment
por: Ahn, Ye Jin, et al.
Publicado: (2014)

Treatment of Corneal Neovascularization Using Anti-VEGF Bevacizumab
por: Krizova, Deli, et al.
Publicado: (2014)

Chemical injury treated with autologous limbal epithelial stem cell transplantation and subconjunctival bevacizumab
por: Cavallini, Gian Maria, et al.
Publicado: (2014)

Subconjunctival ocular filariasis -Case report-
por: Macarie, Sorin Simion, et al.
Publicado: (2017)

Low-dose subconjunctival bevacizumab to augment trabeculectomy for glaucoma
por: Sedghipour, Mohammad-Reza, et al.
Publicado: (2011)

The efficiency of subconjunctival bevacizumab in refractory glaucoma - case report
por: Popescu, V, et al.
Publicado: (2015)

Comment on: Role of subconjunctival bevacizumab in primary pterygium surgery
por: Shivalli, Siddharudha, et al.
Publicado: (2016)

Comparison of the Effects of Subconjunctival Injections of Bevacizumab and Interferon Alpha-2a on Corneal Angiogenesis in a Rat Model
por: Bilgin, Sinan
Publicado: (2018)

Simultaneous Subconjunctival Triamcinolone and Bevacizumab Injections for Management of Blepharokeratoconjunctivitis in Children
por: Nguyen, Chu Luan, et al.
Publicado: (2018)

Intrastromal Injection of Bevacizumab in the Management of Corneal Neovascularization: About 25 Eyes
por: Sarah, Belghmaidi, et al.
Publicado: (2016)

Bevacizumab: Off-label use in ophthalmology
por: Grisanti, Salvatore, et al.
Publicado: (2007)

Intravitreal Bevacizumab (Avastin) Treatment of Neovascular Glaucoma in Ocular Ischemic Syndrome
por: Lee, Sang Joon, et al.
Publicado: (2009)

Subconjunctival Bevacizumab for Primary Pterygium Excision; a Randomized Clinical Trial
por: Razeghinejad, Mohammad-Reza, et al.
Publicado: (2014)

Local ocular safety of the subconjunctival injection of cetuximab in rabbits
por: Aghaei, Hossein, et al.
Publicado: (2023)

Triamcinolone Acetonide as an Adjunct to Bevacizumab for Prevention of Corneal Neovascularization in a Rat Model
por: Mehrjardi, Hadi Z., et al.
Publicado: (2014)

The Effect of Bevacizumab versus Ranibizumab in the Treatment of Corneal Neovascularization: A Preliminary Study
por: Kim, Jin-Hyoung, et al.
Publicado: (2013)

Five-year visual results of intravitreal bevacizumab in refractory inflammatory ocular neovascularization
por: Mansour, Ahmad M, et al.
Publicado: (2012)

Ocular Syphilis with Retinal and Disc Neovascularization Treated with Bevacizumab: A Case Report
por: Comastri, Lucia, et al.
Publicado: (2023)

Subconjunctival Bevacizumab as an Adjunct to Trabeculectomy in Eyes with Refractory Glaucoma: A Case Series
por: Choi, Jin Young, et al.
Publicado: (2010)

Subconjunctival bevacizumab to augment trabeculectomy with mitomycin C in the management of failed glaucoma surgery
por: Saeed, Ahmed M, et al.
Publicado: (2014)

Subconjunctival Bevacizumab Injection in Glaucoma Filtering Surgery: A Case Control Series
por: Wang, Jing, et al.
Publicado: (2013)

Composite Hydrogel Modulates Intrinsic Immune-Cascade Neovascularization for Ocular Surface Reconstruction after Corneal Chemical Injury
por: Zhang, Jun, et al.
Publicado: (2023)

Mechanisms Controlling the Effects of Bevacizumab (Avastin) on the Inhibition of Early but Not Late Formed Corneal Neovascularization
por: Chen, Wei-Li, et al.
Publicado: (2014)

An Update on Novel Ocular Nanosystems with Possible Benefits in the Treatment of Corneal Neovascularization
por: Zhang, Chenchen, et al.
Publicado: (2022)

Management of Uveitis-Related Choroidal Neovascularization: From the Pathogenesis to the Therapy
por: D'Ambrosio, Enzo, et al.
Publicado: (2014)

Ocular syphilis with optic disc neovascularization treated with bevacizumab evaluated by OCT angiography and electroretinography
por: Miura, Gen, et al.
Publicado: (2020)

Postoperative subconjunctival bevacizumab injection as an adjunct to 5-fluorouracil in the management of scarring after trabeculectomy
por: Freiberg, Florentina Joyce, et al.
Publicado: (2013)

Efficiency and safety of subconjunctival injection of anti-VEGF agent – bevacizumab – in treating dry eye
por: Jiang, Xiaodan, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_sofvij9fohform0muq9r9fj8gc